Huipan Liu

713 total citations
48 papers, 453 citations indexed

About

Huipan Liu is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Huipan Liu has authored 48 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 24 papers in Cancer Research and 17 papers in Surgery. Recurrent topics in Huipan Liu's work include Peptidase Inhibition and Analysis (31 papers), Protease and Inhibitor Mechanisms (23 papers) and Cardiac Structural Anomalies and Repair (13 papers). Huipan Liu is often cited by papers focused on Peptidase Inhibition and Analysis (31 papers), Protease and Inhibitor Mechanisms (23 papers) and Cardiac Structural Anomalies and Repair (13 papers). Huipan Liu collaborates with scholars based in China, South Sudan and Macao. Huipan Liu's co-authors include Yue Chen, Xiao Yang, Wenhui Fu, Liang Cai, Yingwei Wang, Xin Yang, Lin Liu, Santao Ou, Junzheng Wang and Yue Zhou and has published in prestigious journals such as Radiology, European Journal of Nuclear Medicine and Molecular Imaging and Cancers.

In The Last Decade

Huipan Liu

46 papers receiving 450 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huipan Liu China 13 366 237 213 112 68 48 453
Cihan Gündoğan Türkiye 10 290 0.8× 143 0.6× 175 0.8× 141 1.3× 96 1.4× 44 425
Halil Kömek Türkiye 13 331 0.9× 147 0.6× 199 0.9× 179 1.6× 154 2.3× 60 508
Emine Göknur Işık Türkiye 10 169 0.5× 66 0.3× 71 0.3× 128 1.1× 118 1.7× 41 313
Esra Arslan Türkiye 9 133 0.4× 55 0.2× 119 0.6× 115 1.0× 52 0.8× 65 281
Veronica Cox United States 10 102 0.3× 134 0.6× 52 0.2× 37 0.3× 89 1.3× 23 357
Silvia Michieletto Italy 13 150 0.4× 240 1.0× 161 0.8× 68 0.6× 213 3.1× 34 501
A. Spada Italy 9 227 0.6× 67 0.3× 85 0.4× 56 0.5× 179 2.6× 17 425
Kentaro Sawada Japan 12 423 1.2× 133 0.6× 173 0.8× 37 0.3× 309 4.5× 59 633
Francesco Deltetto Italy 12 94 0.3× 74 0.3× 60 0.3× 37 0.3× 37 0.5× 20 534

Countries citing papers authored by Huipan Liu

Since Specialization
Citations

This map shows the geographic impact of Huipan Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huipan Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huipan Liu more than expected).

Fields of papers citing papers by Huipan Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huipan Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huipan Liu. The network helps show where Huipan Liu may publish in the future.

Co-authorship network of co-authors of Huipan Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Huipan Liu. A scholar is included among the top collaborators of Huipan Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huipan Liu. Huipan Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yue, et al.. (2024). Prospective comparison of 68Ga-DOTA-ibandronate and bone scans for detecting bone metastases in breast cancer. Frontiers in Oncology. 14. 1428498–1428498. 2 indexed citations
2.
Liu, Yuhong, et al.. (2024). Imaging of desmoplastic small round-cell tumor on 68Ga-FAPI PET/CT. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition). 43(3). 500013–500013. 1 indexed citations
3.
Liu, Huipan, et al.. (2024). Increased Uptake of 68Ga-DOTA-IBA in Multiple Subcutaneous Metastases of Prostate Cancer. Clinical Nuclear Medicine. 49(11). 1062–1064. 1 indexed citations
4.
Liu, Huipan, et al.. (2024). Elevated FAPI Activity in an Adult Brodie Abscess. Clinical Nuclear Medicine. 49(4). 322–323.
5.
Liu, Huipan, et al.. (2024). Incidental Uptake of 68Ga-DOTA-IBA in Prostate Adenocarcinoma. Clinical Nuclear Medicine. 49(12). 1150–1151. 1 indexed citations
6.
Liu, Huipan, Yuhong Liu, Jianwen Zhang, & Yue Chen. (2024). 68Ga-FAPI Response Evaluation Pitfall in a Patient With Esophageal Cancer After Neoadjuvant Therapy. Clinical Nuclear Medicine. 50(1). 70–71. 2 indexed citations
7.
Zhang, Shumao, Wei Wang, Tingting Xu, et al.. (2022). Comparison of Diagnostic Efficacy of [68Ga]Ga-FAPI-04 and [18F]FDG PET/CT for Staging and Restaging of Gastric Cancer. Frontiers in Oncology. 12. 925100–925100. 27 indexed citations
8.
Liu, Huipan, et al.. (2022). Progress on Denosumab Use in Giant Cell Tumor of Bone: Dose and Duration of Therapy. Cancers. 14(23). 5758–5758. 11 indexed citations
9.
Liu, Huipan, Zhi Hu, Xiao Yang, Tianyang Dai, & Yue Chen. (2022). Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F]FDG Uptake in Esophageal Cancer. Frontiers in Oncology. 12. 875081–875081. 17 indexed citations
10.
Liu, Huipan, Xiao Yang, Lin Liu, Lei Lei, & Yue Chen. (2021). Incidental Detection of Sinonasal Inverted Papilloma With 68Ga-FAPI PET/CT in a Patient With Esophageal Cancer. Clinical Nuclear Medicine. 46(10). 845–846. 2 indexed citations
11.
Zhou, Yue, Xin Yang, Huipan Liu, et al.. (2021). Value of [68Ga]Ga-FAPI-04 imaging in the diagnosis of renal fibrosis. European Journal of Nuclear Medicine and Molecular Imaging. 48(11). 3493–3501. 79 indexed citations
12.
Liu, Huipan, Lin Liu, Lin Chen, et al.. (2021). [68Ga]Ga-DOTA-FAPI-04 PET/CT imaging of benign pulmonary solitary fibrous tumour. European Journal of Nuclear Medicine and Molecular Imaging. 48(6). 2053–2054. 16 indexed citations
13.
Wu, Junhao, et al.. (2021). Detection of Nasal Solitary Extramedullary Plasmacytoma on 18F-FDG PET/CT Imaging. Clinical Nuclear Medicine. 46(8). 677–678. 4 indexed citations
14.
Liu, Huipan, Yingwei Wang, Wei Zhang, Liang Cai, & Yue Chen. (2020). Elevated [68Ga]Ga-DOTA-FAPI-04 activity in degenerative osteophyte in a patient with lung cancer. European Journal of Nuclear Medicine and Molecular Imaging. 48(5). 1671–1672. 21 indexed citations
15.
Fu, Wenhui, Lin Liu, Huipan Liu, Zhijun Zhou, & Yue Chen. (2020). Increased FAPI Uptake in Brain Metastasis From Lung Cancer on 68Ga-FAPI PET/CT. Clinical Nuclear Medicine. 46(1). e1–e2. 19 indexed citations
16.
Liu, Huipan, Lin Liu, & Yue Chen. (2020). Thymic carcinoid mimicking mediastinal lymphoma on 18F-FDG PET/CT. Journal of Nuclear Cardiology. 28(3). 1193–1195. 1 indexed citations
17.
Liu, Huipan. (2019). Application progress of radionuclide imaging and therapy in neuroendocrine tumors. 39(9). 564–567. 1 indexed citations
18.
Liu, Huipan, et al.. (2019). Unusual uptake of 131iodine in bilateral ovarian endometriosis cysts in a patient with thyroid cancer. Endocrine. 66(3). 693–694. 3 indexed citations
19.
Liu, Huipan, et al.. (2019). 18F-NaF Uptake in Retroperitoneal Neurofibroma and Uterine Leiomyoma Calcifications. Clinical Nuclear Medicine. 44(12). 991–992. 4 indexed citations
20.
Zhang, Wei, et al.. (2018). FDG PET/CT Imaging of Hepatocellular Carcinoma With Bile Duct Tumor Thrombus. Clinical Nuclear Medicine. 44(2). 130–132. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026